BUZZ-季度业绩不及预期,Esperion 下跌

路透中文
Mar 10
BUZZ-季度业绩不及预期,Esperion 下跌

3月10日 - ** 药物开发商Esperion Therapeutics ESPR.O股价下跌4.61%至2.90美元

** (link) 根据LSEG汇编的数据,该公司公布第四季度调整后利润为每股22美分,而分析师预计为每股24美分。

** 第四季度营收为1.684亿美元,低于分析师预计的1.745亿美元

** ESPR股价在2025年上涨超过68%后,年累计下跌22%

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10